| CYP2C9 Genotype‐guided Warfarin Prescribing Enhances the Efficacy and Safety of Anticoagulation: A Prospective Randomized Controlled Study Y Caraco, S Blotnick, M Muszkat Clinical Pharmacology & Therapeutics 83 (3), 460-470, 2008 | 473 | 2008 |
| Population differences in S‐warfarin metabolism between CYP2C9 genotype‐matched Caucasian and Japanese patients H Takahashi, GR Wilkinson, Y Caraco, M Muszkat, RB Kim, T Kashima, ... Clinical Pharmacology & Therapeutics 73 (3), 253-263, 2003 | 240 | 2003 |
| A common β1‐adrenergic receptor polymorphism (Arg389Gly) affects blood pressure response to β‐blockade GG Sofowora, V Dishy, M Muszkat, HG Xie, RB Kim, PA Harris, ... Clinical Pharmacology & Therapeutics 73 (4), 366-371, 2003 | 224 | 2003 |
| Comparing the clinical efficacy of COVID-19 vaccines: a systematic review and network meta-analysis V Rotshild, B Hirsh-Raccah, I Miskin, M Muszkat, I Matok Scientific reports 11 (1), 22777, 2021 | 196 | 2021 |
| Acute renal failure with sodium-glucose-cotransporter-2 inhibitors: analysis of the FDA adverse event report system database A Perlman, SN Heyman, I Matok, J Stokar, M Muszkat, A Szalat Nutrition, Metabolism and Cardiovascular Diseases 27 (12), 1108-1113, 2017 | 103 | 2017 |
| Differential in vivo sensitivity to inhibition of P-glycoprotein located in lymphocytes, testes, and the blood-brain barrier EF Choo, D Kurnik, M Muszkat, T Ohkubo, SD Shay, JN Higginbotham, ... Journal of Pharmacology and Experimental Therapeutics 317 (3), 1012-1018, 2006 | 97 | 2006 |
| Fluoroquinolones and cardiovascular risk: a systematic review, meta-analysis and network meta-analysis E Gorelik, R Masarwa, A Perlman, V Rotshild, M Abbasi, M Muszkat, ... Drug safety 42, 529-538, 2019 | 95 | 2019 |
| Onset, duration and unresolved symptoms, including smell and taste changes, in mild COVID-19 infection: a cohort study in Israeli patients H Klein, K Asseo, N Karni, Y Benjamini, R Nir-Paz, M Muszkat, S Israel, ... Clinical Microbiology and Infection 27 (5), 769-774, 2021 | 86 | 2021 |
| Can SGLT2 inhibitors cause acute renal failure? Plausible role for altered glomerular hemodynamics and medullary hypoxia A Szalat, A Perlman, M Muszkat, M Khamaisi, Z Abassi, SN Heyman Drug safety 41, 239-252, 2018 | 82 | 2018 |
| Phenytoin metabolic ratio: a putative marker of CYP2C9 activity in vivo Y Caraco, M Muszkat, AJJ Wood Pharmacogenetics and Genomics 11 (7), 587-596, 2001 | 73 | 2001 |
| Systematic review, meta-analysis, and network meta-analysis of the cardiovascular safety of macrolides E Gorelik, R Masarwa, A Perlman, V Rotshild, M Muszkat, I Matok Antimicrobial agents and chemotherapy 62 (6), 10.1128/aac. 00438-18, 2018 | 68 | 2018 |
| Local and systemic immune response in nursing-home elderly following intranasal or intramuscular immunization with inactivated influenza vaccine M Muszkat, E Greenbaum, A Ben-Yehuda, M Oster, E Yeu, S Heimann, ... Vaccine 21 (11-12), 1180-1186, 2003 | 65 | 2003 |
| Beta-1-adrenoceptor genetic variants and ethnicity independently affect response to beta-blockade D Kurnik, C Li, GG Sofowora, EA Friedman, M Muszkat, HG Xie, PA Harris, ... Pharmacogenetics and genomics 18 (10), 895-902, 2008 | 64 | 2008 |
| Warfarin metabolism and anticoagulant effect: a prospective, observational study of the impact of CYP2C9 genetic polymorphism in the presence of drug-disease and drug-drug … M Muszkat, S Blotnik, A Elami, I Krasilnikov, Y Caraco Clinical Therapeutics 29 (3), 427-437, 2007 | 60 | 2007 |
| CYP2A6 genetic variation and dexmedetomidine disposition U Kohli, P Pandharipande, M Muszkat, GG Sofowora, EA Friedman, ... European journal of clinical pharmacology 68, 937-942, 2012 | 59 | 2012 |
| Effects of variation in the human α2A-and α2C-adrenoceptor genes on cognitive tasks and pain perception U Kohli, M Muszkat, GG Sofowora, PA Harris, EA Friedman, WD Dupont, ... European Journal of Pain 14 (2), 154-159, 2010 | 54 | 2010 |
| Major bleeding and hemorrhagic stroke with direct oral anticoagulants in patients with renal failure: systematic review and meta-analysis of randomized trials BH Raccah, A Perlman, HD Danenberg, A Pollak, M Muszkat, I Matok Chest 149 (6), 1516-1524, 2016 | 53 | 2016 |
| Ethnic and Genetic Determinants of Cardiovascular Response to the Selective α2-Adrenoceptor Agonist Dexmedetomidine D Kurnik, M Muszkat, GG Sofowora, EA Friedman, WD Dupont, ... Hypertension 51 (2), 406-411, 2008 | 53 | 2008 |
| Local and systemic immune response in community‐dwelling elderly after intranasal or intramuscular immunization with inactivated influenza vaccine M Muszkat, AB Yehuda, MH Schein, Y Friedlander, P Naveh, ... Journal of medical virology 61 (1), 100-106, 2000 | 51 | 2000 |
| Association between use of pharmacokinetic‐interacting drugs and effectiveness and safety of direct acting oral anticoagulants: nested case‐control study N Gronich, N Stein, M Muszkat Clinical Pharmacology & Therapeutics 110 (6), 1526-1536, 2021 | 48 | 2021 |
